Persistent Complete Response After Single-agent Sunitinib Treatment in a Case of TFE Translocation Positive Relapsed Metastatic Pediatric Renal Cell Carcinoma

被引:22
作者
Chowdhury, Tanzina [2 ]
Prichard-Jones, Kathryn [1 ,2 ]
Sebire, Neil J. [3 ]
Bier, Nelly [3 ]
Cherian, Abraham [4 ]
Sullivan, Maureen O. [5 ]
O'Meara, Anne [5 ]
Anderson, John [1 ,2 ]
机构
[1] UCL Inst Child Hlth, Unit Mol Haematol & Canc Biol, London WC1N 1EH, England
[2] Great Ormond St Hosp Sick Children, Dept Oncol, London, England
[3] Great Ormond St Hosp Sick Children, Dept Histopathol, London, England
[4] Great Ormond St Hosp Sick Children, Dept Urol, London, England
[5] Our Ladys Hosp Sick Children, Dublin, Ireland
关键词
renal cell carcinoma; TFE3; Xp11; sunitinib; UP-REGULATION; INHIBITION; NEOPLASMS; FUSIONS; TUMORS;
D O I
10.1097/MPH.0b013e318266bf34
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Forty percent of renal cell carcinomas (RCCs) in childhood are characterized by translocation involving transcription factor E3 (TFE3) family members. Here, we describe a case of TFE3-positive RCC in which metastatic relapse to the mediastinal lymph nodes and pulmonary nodules was treated with single-agent sunitinib, a multitargeted tyrosine inhibitor. Complete radiologic remission was achieved after only 3 courses of treatment, and surgical exploration of metastases failed to identify any residual viable disease. The published experience of sunitinib in TFE-RCC is limited, and prospective evaluation of its activity in a larger number of patients is warranted.
引用
收藏
页码:E1 / E3
页数:3
相关论文
共 14 条
[1]   Distinctive neoplasms characterised by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas [J].
Argani, P ;
Ladanyi, M .
PATHOLOGY, 2003, 35 (06) :492-498
[2]   Recent advances in pediatric renal neoplasia [J].
Argani, P ;
Ladanyi, M .
ADVANCES IN ANATOMIC PATHOLOGY, 2003, 10 (05) :243-260
[3]   Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions -: A sensitive and specific immunohistochemical assay [J].
Argani, P ;
Lal, P ;
Hutchinson, B ;
Lui, MY ;
Reuter, VE ;
Ladanyi, M .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2003, 27 (06) :750-761
[4]   A Case of Adult Metastatic Xp11 Translocation Renal Cell Carcinoma Treated Successfully With Sunitinib [J].
Choueiri, Toni K. ;
Mosquera, Juan-Miguel ;
Hirsch, Michelle S. .
CLINICAL GENITOURINARY CANCER, 2009, 7 (03) :E93-E94
[5]   Recent progress in the management of advanced renal cell carcinoma [J].
Garcia, Jorge A. ;
Rini, Brian I. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (02) :112-125
[6]   Translocation renal cell carcinoma - Lack of negative impact due to lymph node spread [J].
Geller, James I. ;
Argani, Pedram ;
Adeniran, Adebowale ;
Hampton, Edith ;
De Marzo, Angelo ;
Hicks, Jessica ;
Collins, Margaret H. .
CANCER, 2008, 112 (07) :1607-1616
[7]   Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution [J].
Kuiper, RP ;
Schepens, M ;
Thijssen, J ;
van Asseldonk, M ;
van den Berg, E ;
Bridge, J ;
Schuuring, E ;
Schoenmakers, EFPM ;
van Kessel, AG .
HUMAN MOLECULAR GENETICS, 2003, 12 (14) :1661-1669
[8]   Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network [J].
Malouf, G. G. ;
Camparo, P. ;
Oudard, S. ;
Schleiermacher, G. ;
Theodore, C. ;
Rustine, A. ;
Dutcher, J. ;
Billemont, B. ;
Rixe, O. ;
Bompas, E. ;
Guillot, A. ;
Boccon-Gibod, L. ;
Couturier, J. ;
Molinie, V. ;
Escudier, B. .
ANNALS OF ONCOLOGY, 2010, 21 (09) :1834-1838
[9]   A case study of metastatic Xp11.2 translocation renal cell carcinoma effectively treated with sunitinib [J].
Numakura, Kazuyuki ;
Tsuchiya, Norihiko ;
Yuasa, Takeshi ;
Saito, Mitsuru ;
Obara, Takashi ;
Tsuruta, Hiroshi ;
Narita, Shintaro ;
Horikawa, Yohei ;
Satoh, Shigeru ;
Habuchi, Tomonori .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (05) :577-580
[10]   Pediatric renal tumors: Practical updates for the pathologist [J].
Perlman, EJ .
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2005, 8 (03) :320-338